WDR6 and B-cell non-Hodgkin lymphoma: As shown in Figure 2V−W, we found that the OS of blood cancer patients including B‐Cell Lymphoma and DLBCL in the WDR6 high‐expression group were significantly shorter than the low‐expression group.